IL-2mAb reduces demyelination after focal cerebral ischemia by suppressing CD8+ T cells.
Yu-Xi ZhouXin WangDan TangYan LiYing-Fu JiaoYu GanXiao-Ming HuLi-Qun YangWei-Feng YuRuth Anne StetlerPei-Ying LiDa-Xiang WenPublished in: CNS neuroscience & therapeutics (2018)
IL-2mAb preserved white matter integrity and improved long-term sensorimotor functions following cerebral ischemic injury. The activation and brain infiltration of CD8+ T cells are detrimental for demyelination after stroke and may be the major target of IL-2mAb posttreatment in the protection of white matter integrity after stroke.